BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Vinogradskiy Y, Diot Q, Jones B, Castillo R, Castillo E, Kwak J, Bowles D, Grills I, Myziuk N, Guerrero T, Stevens C, Schefter T, Gaspar LE, Kavanagh B, Miften M, Rusthoven C. Evaluating Positron Emission Tomography-Based Functional Imaging Changes in the Heart After Chemo-Radiation for Patients With Lung Cancer. Int J Radiat Oncol Biol Phys 2020;106:1063-70. [PMID: 31983558 DOI: 10.1016/j.ijrobp.2019.12.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Zakem SJ, Jones B, Castillo R, Castillo E, Miften M, Goodman KA, Schefter T, Olsen J, Vinogradskiy Y. Cardiac metabolic changes on 18 F-positron emission tomography after thoracic radiotherapy predict for overall survival in esophageal cancer patients. J Appl Clin Med Phys 2022;:e13552. [PMID: 35243772 DOI: 10.1002/acm2.13552] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Eber J, Leroy-freschini B, Antoni D, Noël G, Pflumio C. Increased cardiac uptake of (18F)-fluorodeoxyglucose incidentally detected on positron emission tomography after left breast irradiation: How to interpret? Cancer/Radiothérapie 2022. [DOI: 10.1016/j.canrad.2021.10.010] [Reference Citation Analysis]
3 Cella L, Monti S, Xu T, Liuzzi R, Stanzione A, Durante M, Mohan R, Liao Z, Palma G. Probing thoracic dose patterns associated to pericardial effusion and mortality in patients treated with photons and protons for locally advanced non-small-cell lung cancer. Radiother Oncol 2021;160:148-58. [PMID: 33979653 DOI: 10.1016/j.radonc.2021.04.025] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
4 Miller R, Santangelo T, Forghani-arani F, Rusthoven C, Chen Y, Castillo E, Castillo R, Guerrero T, Vinogradskiy Y. Changes in post-treatment cardiac PET avidity predict overall survival in lung cancer patients treated with chemoradiation: secondary analysis of the ACRIN 6668/RTOG 0235 clinical trial. Radiotherapy and Oncology 2022. [DOI: 10.1016/j.radonc.2022.04.003] [Reference Citation Analysis]
5 Cho SG, Kim YH, Park H, Park KS, Kim J, Ahn SJ, Bom HS. Prediction of cardiac events following concurrent chemoradiation therapy for non-small-cell lung cancer using FDG PET. Ann Nucl Med 2022. [PMID: 35175561 DOI: 10.1007/s12149-022-01724-w] [Reference Citation Analysis]
6 Schonewolf CA, Jolly S, Dess RT. Particle Beam Therapy for Cardiac-Sparing Radiotherapy in Non-Small Cell Lung Cancer. Semin Radiat Oncol 2021;31:112-9. [PMID: 33610267 DOI: 10.1016/j.semradonc.2020.11.005] [Reference Citation Analysis]